KORRO BIO INC. - COMM
35.91
07-October-24 14:59:55
15 minutes delayed
Stocks
+2.32
+6.91%
Today's range
32.00 - 35.99
ISIN
N/A
Source
NASDAQ
-
30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
16 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro to Participate in Upcoming Investor Conferences
10 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro to Participate in Upcoming September Investor and Scientific Conferences
27 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
13 Aug 2024 15:01:00 By Nasdaq GlobeNewswire
-
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
01 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro to Participate in Upcoming June Investor and Scientific Conferences
30 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
20 May 2024 13:30:00 By Nasdaq GlobeNewswire
-
14 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
Korro Announces $70 Million Private Placement
18 Apr 2024 07:30:59 By Nasdaq GlobeNewswire
-
Korro to Participate in Upcoming Investor Conferences
01 Apr 2024 15:01:00 By Nasdaq GlobeNewswire
-
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress
26 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
Korro to Present at the TD Cowen 44th Annual Health Care Conference
27 Feb 2024 07:00:01 By Nasdaq GlobeNewswire
-
18 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
07 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >